Viewing Study NCT00778557


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2025-12-30 @ 5:57 PM
Study NCT ID: NCT00778557
Status: COMPLETED
Last Update Posted: 2008-10-23
First Post: 2008-10-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions
Sponsor: Ranbaxy Laboratories Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module